Decision | Consent granted Section 12(b) Overseas Investment Act 2005 Section 13(1)(a) Overseas Investment Act 2005 |
---|---|
Decision date | 22 October 2014 |
Investment | An overseas investment in sensitive land, being the Applicant's acquisition of rights or interests in up to 100% of the shares of Acurity Health Group Limited which owns or controls:
An overseas investment in significant business assets, being the Applicant's acquisition of rights or interests in up to 100% of the shares of Acurity Health Group Limited, the consideration of which exceeds $100m. |
Consideration | $125,134,703 |
Applicant | Connor Healthcare Limited Austron Limited, New Zealand (75.0%) Evolution Healthcare (NZ) Pty Ltd, Australia (25.0%) |
Vendor | Existing shareholders of Acurity Health Group Limited New Zealand Public (100%) |
Background | The Applicant will be a subsidiary of Evolution Healthcare (NZ) Pty Ltd ("Evolution") and Austron Limited ("Austron"). Both Evolution and Austron currently have an ownership interest in Acurity Health Group Limited, which is a private healthcare provider, including owning and operating private hospitals such as Bowen and Royston Hospitals. A takeover offer has been made for the remaining shares in Acurity Health Group Limited. The Applicant intends to introduce new systems to Acurity Health Group Limited’s hospitals to improve efficiency. The overseas investment transaction has satisfied the criteria in sections 16 and 18 of the Overseas Investment Act 2005. The 'benefit to New Zealand' criterion was satisfied by particular reference to the following factors: Overseas Investment Act 2005 Overseas Investment Regulations 2005 |
More information | Michael Harrod Mayne Wetherell PO Box 3797 Shortland Street AUCKLAND |